Tomographic brain imaging techniques repre sented an innovative tool for exploring cerebral anatomy in vivo. However, in spite of prominent clinical deficits, X-ray computed tomography (CT) provides only minor information in many disorders of the central nervous system (CNS), including Par kinson's disease (PD) and Alzheimer's disease (AD).
Interest in elucidating changes of brain functional activity mediating the clinical signs has led to the use of techniques, such as positron emission tomog raphy (PET) and single photon emission computed tomography (SPECT), for in vivo mapping of re gional rates of cerebral metabolism (rCMR) and blood flow (rCBF). Both techniques have revealed alterations of rCMR/rCBF in patients with PD and AD, even though some findings were controversial.
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basal ganglia increased with the severity of the disease. Significant reductions of tracer uptake, from control val ues, were observed bilaterally in the parietal cortex. These deficits were more pronounced in patients with mental deterioration and in subjects who had been chron ically treated with anticholinergic drugs. Parietal perfu sion deficits in parkinsonian patients resemble those de scribed in Alzheimer's dementia. These findings suggest that the heterogeneous alterations of regional cerebral blood flow (rCBF) in parkinsonian patients reflect the multifactorial pathophysiology of the disease. Key Words: Cerebral blood flow-HM-PAO-Parkinson's disease SPECT.
Whereas there is general agreement that AD typi cally shows defects of perfusion and metabolism in the parietal cortex (Foster et aI., 1983; Duara et al. , 1986; Deutsch and Tweedy, 1987; Jagust et aI., 1987) , local alterations in metabolism and blood flow have not been consistently observed in PD. Since parkinsonism results from degeneration of the dopaminergic nigrostriatal neurons (Hornykiewicz, 1966) , one would expect that dopamine depletion within the basal ganglia might result in consistent alterations of local functional activity and, conse quently, of rCMR and rCBF. However, metabolism and blood flow have been reported to be reduced (Henriksen and Boas, 1985) , increased (Martin et aI., 1984; Wolfson et aI., 1985) , or unchanged (Rougemont et aI., 1983; Kuhl et aI., 1984) , from control values, in the basal ganglia of parkinsonian patients. In addition, diffuse or focal cortical abnor malities have been reported (Lenzi et aI., 1979; Kuhl et aI., 1984; Globus et aI., 1985; Perlmutter and Raichle, 1985) .
In this study, we investigated a group of PD pa tients using SPECT and [ 99 ffiTc]_HM_PAO ([ 99 ffiTc]-hexamethylpropyleneamine oxime) as a tracer. This substance readily crosses the blood-brain barrier and is taken up by the brain to a similar extent as 123 I-Iabeled derivatives of amphetamine (Ell et aI., 1985; Leonard et aI., 1986) . Its minimal redistribution and long residence time allow con ventional equipment to be used for SPECT imaging (Sharp et aI., 1986) . The regional concentration of the tracer is blood flow related (N eirinckx et aI., 1987) . The aim of the study was to explore func tional correlates in characteristic subgroups of PD patients.
MATERIALS AND METHODS

Subjects
Thirty-six patients suffering from idiopathic PD (22 men and 14 women), and 10 age-matched control subjects were studied. Patient data are summarized in Table 1 . Their mean age at study was 63.5 years (range of 40-78 years). Duration of symptoms ranged from 2 months to 16 years (mean of 4.3 years). Six patients had parkinsonian signs limited to one side only. Among subjects with evi dence of bilateral disease, symptoms were predominantly unilateral in most cases. Twenty-three patients were on chronic DOPA (3,4-dihydroxyphenylalanine, plus periph eral decarboxylase inhibitors) therapy (from 6 months to 15 years), 21 were taking anticholinergic drugs, whereas 8 patients had never been treated with anti parkinsonian medication before.
All subjects underwent a detailed medical and neuro- 
a Exclusively or predominantly right (R) or left (L) limb in volvement.
b Mini Mental State examination score (Folstein et aI., 1975 (1967) . Neuropsychologic evaluations for de mentia and depression were also carried out. The severity of dementia was estimated using the Mini-Mental State (MMS) test (Folstein et aI., 1975) . Cognitive deficits were evident in seven patients (MMS score between 10-23).
Control subjects (six men and four women, mean age of 57.8 years, range of 43 to 80 years) were medically and neurologically screened, as described above. They were not on any form of chronic medication. 
Patient preparation
Data acquisition and analysis
SPECT scanning was performed with a single-head ro tating gamma camera fitted with low-energy high resolu tion parallel-hole collimator and equipped with a com puter system (Philips Gamma Diagnost-MDS system). Sixty-four views, each collected over 30 s, were recorded into a 64 x 64 matrix format on a 3600 rotation, with the subject's head immobilized. Transaxial slices were recon structed from the prefiltered raw data (9-point weighted filter) by the filtered backprojection algorithm using a ramp filter. Sorenson's technique (1974) (fL = 0. 12 cm -1) was used for attenuation correction, whereas no scatter correction was applied. Transaxial sections at 6 mm in tervals were used for reconstructing 1.2 cm thick com puted images in planes parallel to the orbitomeatal line, and in sagittal and coronal planes as well. The resolution of this imaging system has been measured to be 15 mm full width at half-maximum (FWHM) in the plane of the reconstructed transverse sections.
A semiquantitative method of assessing regional tracer uptake was used. Regions of interest (ROI; 3 x 3 pixels, 18 x 18 mm) were drawn on five orbitomeatal slices by an operator trained in neuroanatomy with reference to a standard CT brain atlas (Matsui and Hirano, 1978) . Re gional radioactivity count densities were obtained for a total of 10 pairs of bilateral regions. ROIs in this study included cerebellar hemispheres, cortical regions (medial and lateral frontal, anterior and posterior temporal, pari etal, and occipital), regions centered over the basal gan glia (caudate-putamen, globus pallidus) and the thalamus. Relative tracer activity was expressed as a ratio of activ ity in each ROI to mean counting rate over the cerebellar regions, corrected for early back diffusion of the tracer with the correction algorithm proposed by Lassen et aI. (1988) .
Statistical comparisons between comparable regions of control subjects and Parkinson's patients were made us ing the two-tailed Student's t test. The criterion of statis tical significance was p < 0.05. mTcJ-HM-PAO SPECT IN PARKINSON'S DISEASE S103
RESULTS
Control subjects showed a homogeneous distri bution of the radiotracer in the frontal, parietal, and temporal cortices. Activity ratios were higher in the occipital cortex and subcortical regions. Although right-to-left asymmetries in the basal ganglia re gions were observed in individual cases, overall mean values were not significantly different on the two sides (Fig. 1) .
The clinical characteristics of PD patients in cluded in this study are summarized in Table 1 . In evaluating the effects of the disease on rCBF, as detected by [ 99 mTc]-HM-PAO SPECT, subgroups of patients were separated in relation to lateraliza tion of symptoms, duration and severity of the dis ease, cognitive deterioration, and previous treat ment regimens.
As shown in Table 2 , most of the regions exam ined did not show any significant change in mean tracer uptake between PD and normal subjects. In particular, overall mean blood flow ratios in the basal ganglia regions were practically the same in the parkinsonian patients as in the control subjects. Furthermore, mean blood flow values, expressed in % of cerebellar flow, for caudate-putamen and glo bus pallidus were similar in the different groups of PD patients defined on the basis of clinical param eters such as duration and severity of the disease. However, previous chronic therapy appeared to Each number represents the ratio (±SD) of mean (right and left) activity in each region of interest to the mean activity for the cerebellar hemispheres (x 100), corrected for early backdiffusion of the tracer (Lassen et aI., 1988) .
Number of subjects in each group is shown in parentheses. a Significantly different from mean control values (p < 0.05).
have a significant influence on tracer uptake in cau date-putamen, since subjects chronically treated with DOPA showed significantly higher caudate putaminal values compared to both untreated and to patients treated by DOPA and anticholinergic drugs combined (Fig. 2) . ganglia activity of the whole group of PD patients with exclusively or predominantly unilateral clinical signs did not reveal a specific pattern of alterations. Forty-six percent of the subjects show no or small (less than 10%) right-left differences (Fig. 3) , whereas in about one-half of the cases both in creases and decreases contralateral to the affected limbs were noticed (Fig. 4) . Higher activity in the basal ganglia regions contralateral to the symptoms was a prevalent observation (37% of the patients), and in most instances (27%) it was localized in the medial part of the basal ganglia (globus pallidus). However, when patients with unilateral symptoms were separated on the basis of the severity of the disease (Hoehn-Yahr scale), the percentage of pa tients with right-left asymmetries in the basal gan glia showed a consistent correlation with the pro gression of the disease. Asymmetric basal ganglia rCBF was found in 25% of the stage I subjects, in 58% of the subjects with stage II-III, and in 83% of the patients stage IV-V disease. Increased HM PAO activity contralateral to the affected limbs was found in 12% of the stage I patients, in 33% of the subjects with stage II-III, and in 67% of the patients with stage IV-V disease. Mean activity ratios in most cortical regions of PD patients were similar to control values. Parietal cortex was an exception and a significant reduction of tracer uptake in PD was found in this brain re gion. These deficits were bilateral in most cases (Fig. 5) , and increased with the severity of the dis ease and the degree of mental deterioration. How ever, the contributory effect of previous therapy with anticholinergic drugs should be pointed out. In fact, mean parietal activity was 67 in subjects who received DOPA alone, and 53 in patients previously treated with anticholinergics, regardless of the de gree of cognitive deficits (Table 3) .
CAUDATE -PUTAMEN
DISCUSSION
The critical pathological process of PD is the de generation of dopamine-containing neurons in the pars compacta of the substantia nigra. The de creased dopaminergic innervation within the stria tum is responsible for the clinical manifestations of PD (Hornykiewicz, 1966) . Accordingly, human studies in vivo with PET and fluorine-18-labeled DOPA demonstrated a reduction of striatal dopa mine storage in PD (Leenders et aI., 1986) . How ever, in this study, we found no differences be tween the patients' mean HM-PAO uptake in the basal ganglia regions and control values. Right to-left asymmetries were noticed in individual cases. Such asymmetries tended to be largest with The numbers represent parietal cortex mean activity ratios (±SD) (see legend to Table 2 ) in subgroups of parkinsonian pa tients separated in relation to duration and severity of the dis ease, signs of dementia (Mini Mental State exam score 10-22), and previous chronic therapy.
a Significantly different from values of anticholinergics (p < 0.05) and DOPA + anticholinergics (p < 0.01) treated patients.
increasing severity of the disease, but were unre lated to the prevalent side of motor disturbances. In fact, both contralateral and ipsilateral decreases were observed. These findings seem to indicate that the imbalance of the nigrostriatal axis does not pro duce unequivocal alterations of local functional ac tivity in the target regions.
Previous studies also produced somewhat contra dictory results. Basal ganglia rCBF and/or rCMR have been reported to be unchanged (Rougemont et aI., 1983; Kuhl et aI., 1984) , decreased (Henriksen and Boas, 1985) , or increased (Martin et aI., 1984; Wolfson et aI., 1985) in PD patients. Asymmetric basal ganglia flow/metabolism has been found in some. but not all, subjects. Although increases in the globus pallidus contralateral to the symptoms were a frequent finding, Perlmutter and Raichle (1985) reported pallidal rCBF asymmetries unre lated to the side of motor impairments.
Different factors may account for such heteroge neous findings. First, it should be pointed out that a significant decline of dopaminergic neurotransmis sion occurs in normal aging (McGeer et aI., 1977) . Bernheimer et ai. (1973) showed that a high degree, about 80%, of striatal dopamine loss may occur in aged subjects without an overt parkinsonian symp tomatology. When striatal dopamine content falls below 20%, symptoms become clinically manifest. In other words, small neurochemical differences may separate elderly normal from parkinsonian subjects. These differences may not be sufficient to produce significant changes in rCBF/rCMR be tween the different groups of patients. Second, the relationship between basal ganglia functional activity and alterations of dopaminergic 1988 neurotransmission is complex. Studies in animals have shown different responses of striatal glucose utilization to dopaminergic drugs, in relation to their interaction with subpopulations of dopamine receptors (Pizzolato et aI., 1984 (Pizzolato et aI., , 1985 (Pizzolato et aI., , 1987 . Ac cordingly, an imbalance of the dopaminergic recep tors, or of their subgroups, due to the disease or to chronic specific therapy (Guttman and Seeman, 1986) , may individually condition the functional state of the basal ganglia. These observations may account for the prevalence of asymmetric basal gan glia rCBF in subjects with more severe symptom atology and for the increased HM-PAO activity in caudate-putamen of patients on chronic therapy with DOPA.
Finally, although dopamine deficiency is the main neurochemical correlate of PD, other neurotrans mitters appear to be involved, at least to a certain extent. For instance, deficits in adrenergic (Rinne and Sonninen, 1973) , cholinergic (Ruberg et aI., 1982) , GABAergic (Lloyd et aI., 1977) , and pepti dergic (Studler et aI., 1982 ) systems have all been described. Therefore, the functional alteration of the basal ganglia can be regarded as the integrated result of the imbalance of multiple neurotransmit ters, each one contributing to a different degree in individual cases.
Reduction in cortical flow/metabolism, either re gional or total, is a relatively common finding in parkinsonian patients (Globus et aI., 1985; Perlmut ter and Raichle, 1985) . In particular, a predominant impairment of oxidative metabolism in the parietal cortex has been described by Lenzi et ai. (1979) and by Kuhl et ai. (1984) . Bilateral perfusion deficits in the parietal cortex, as we found in PD, have been observed in AD p atients by our group (Battistin et aI., 1987) and others (Deutsch and Tweedy, 1987; J agust et aI., 1987) . This similarity supports the con cept that the two diseases may overlap to some ex tent. Clinical, pathological, and neurochemical ev idence support this view. Mental changes, similar to those of AD, may develop in a significant percent age of PD patients (Lieberman et aI., 1979; Boller, 1980) . Neuronal loss, senile plaques, neurofibrillary tangles, and granulovacuolar degeneration have been observed in the cortex and other brain regions of PD and AD patients (Hakim and Mathieson, 1979; Boller et aI., 1980) . A decline in cholinergic neurotransmission, which is thought to be respon sible for the memory loss in AD, has been shown in PD patients with dementia (Ruberg et aI., 1982; Whitehouse et aI., 1983) .
In addition, we found a low parietal rCBF in pa tients chronically treated with anticholinergic drugs, unrelated to the degree of mental deteriora-tion. The significance of this association in not fully understood. Our findings, however, suggest that re ceptor dysregulation due to chronic therapy may result in parietal cortex hypofunction. In animals, lesions of the nucleus basalis (London et aI., 1984) or the administration of scopolamine reduced glucose utilization in the rat cerebral cortex, whereas the agonists oxotremorine or arecoline increased it, particularly in the parietal cortex (Dam et aI., 1982 , Soncrant et aI., 1985 . Furthermore, Holman et al. (1985) , using a specific radioligand for the cholinergic system with SPECT, found reductions in the posterior temporoparietal regions in one AD patient.
In conclusion, two major observations emerge from our data on SPECT with [ 99 mTc]_HM_PAO in parkinsonian patients: (a) although changes in rCBF in the basal ganglia have been observed in many subjects, PD is not characterized by a consistent pattern of flow alterations in this region; (b) a more consistent pattern of reduced blood flow has been found in the parietal cortex, in most cases associ ated with deficits of cognitive functions. The heter ogeneity of rCBF changes in PD would seem to reflect the multifactorial pathophysiology of the dis ease. Furthermore, our results also suggest that, among other factors, chronic specific therapy may play a major role in conditioning the fu nctional state of the brain as expressed in energy metabolism and blood flow in degenerative neurological disorders.
